CURIOX APPLICATIONS

COVID-19 & INFECTIOUS DISEASE

Reduce aerosol generation from infectious samples to improve biosafety.

Overview

CHANGE THE WAY YOU PROCESS CELLS TO GET RELIABLY CONSISTENT DATA.

The World Health Organization Laboratory guidance for research on the novel coronavirus SARS-CoV2 states, “all technical procedures should be performed in a way that minimizes the generation of aerosols and droplets.”

Table 1. Risk prioritization of selected routine laboratory tasks
Task or activityExposure risk   
Potential hazardLikelihoodConsequenceRisk rating
Subculturing blood culture bottleNeedle stick — percutaneous inoculationLikelyInfection; medical treatmentHigh
Aerosols — inhalationModerateInfection; medical treatmentMedium
Splash — direct contact with mucous membranesModerateInfection; medical treatmentHigh
CentrifugationAerosols — inhalationLikelyInfection; medical treatmentHigh
Performing Gram stainAerosols from flaming slidesModerateColonization; infectionModerate
Preparing AFB smear onlyAerosols from sputum or slide preparationLikelyIllness; medical treatment; diseaseHigh
Performing catalase testingAerosols — mucous membrane exposureUnlikelyColonization; infectionLow
AFB culture work-upAerosols — inhalationLikelyIllness; medical treatment; diseaseHigh
Abbreviation: AFB = acid-fast bacillus.

Curiox Biosystems introduces a new, safer method for preparing potentially or known infectious blood samples for immune cell profiling without a centrifuge, eliminating aerosolization of potentially infectious samples. The method combines a new configuration of the Laminar Wash HT2000 system packaged with STEMCELL Technologies EasySep RBC depletion reagent to enable blood sample processing within a biosafety cabinet from start to finish.

This natural and gentle cell prep method relying on Laminar Wash technology improves viability, retention, and staining resolution of rare and sensitive immune cell subsets known to play crucial roles in the immune response against COVID-19 infections, like monocytes and neutrophils. Improvements in data quality due to reduced stress are evident even on fragile cells resulting from harsh methods such as red blood cell lysis that relies upon repeated centrifugation steps.

“The Laminar Washer is safer than flicking [minimizing exposure to infectious materials] and requires less space than centrifuges.”

Traditional centrifugation

VS

Laminar flow technology

Comparison of an immuno-staining workflow for the preparation of a single cell suspension for flow cytometry analysis. Laminar Wash technology is equally effective in washing but without the use of a centrifuge.

Benefits

Laminar wash for single cell sequencing & proteogenomics

The compact sizes of the Laminar Wash HT2000 and Laminar Wash MINI means easy containment in a biosafety cabinet. Laminar Wash technology can improve infectious disease sample preparation by:
Featured Resource

Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction

Scientific Data

Data using the laminar wash system

LW is Gentle on Both Neutrophils and Monocytes

Laminar Wash technology was compared to centrifugation protocols in a 16-color immune profiling panel using 100μL of whole human blood. One-step washing using Laminar Wash minimized cell perturbations compared to multiple centrifugation steps, increasing retention of both the monocyte and neutrophil populations.

Better Debris Removal and Cell Retention

When performing cell dissociation in tumor-bearing tissues, tissue debris and enzymatic-induced fragments are primary factors affecting recovery of tumor infiltrating lymphocytes (TILs). For more invasive and immunologically challenging models, like B16F10-inoculated mice, recovery of limited numbers of TILs hinders accurate characterization. Here, Laminar Wash technology was compared to conventional methods for preparing an unchallenged mouse sample containing ~1,000,000 tumor infiltrate cells. Laminar Wash improved viable cell count and reduced debris formation. The cleaner sample preparation increased lymphocyte recovery up to 90.6%, compared to 10.5% for the centrifuge.
Data adapted from the Curiox Biosystems webinar by Dr. Christoph S. Eberle, Discovery Research Services at Charles River Laboratories, Worcester, MA

RELATED PRODUCTS AND ACCESSORIES

Curiox Laminar Wash

LAMINAR WASH™ HT2000 SYSTEM

Achieve higher throughputs and cleaner data with our 96-well laminar washing system.

curiox ht 2000 cytosens
Curiox Laminar Wash Auto

LAMINAR WASH™ AUTO 1000 SYSTEM

Accelerate high-throughput flow and mass cytometry workflows with fully automated sample preparation.